Abstract
The aim of this study is to translate, adapt, and validate a Persian version of the Fibromyalgia (FM) Impact Questionnaire (FIQ-P). The FIQ-P was adapted following the translation and back-translation approach; then, it was administered to thirty females with FM. Participants also completed two other validated questionnaires, the Medical Outcome Survey Short Form-36 (SF-36) and the Beck Depression Inventory (BDI). Internal consistency within the FIQ-P items and its test–retest reliability were assessed with Cronbach’s alpha and Spearman’s correlation coefficient, respectively. Construct validity was analyzed by Spearman’s r when correlating the FIQ-P to other questionnaires. The translated version was concordant. Adaptation affected two sub-items of physical function. Participants’ mean age ± standard deviation was 40.4 ± 9.0 years. Internal consistency proved good with α = 0.80. Test–retest coefficient ranged from 0.50 for the item “work days missed” to 0.79 for all FIQ-P items. Fair and statistically significant (P < 0.01) correlations were found between the FIQ-P items and two other questionnaires, SF-36 (r = −0.57) and BDI (r = 0.53). We concluded that the FIQ-P is a valid and reliable instrument for measuring health status of Persian-speaking FM patients.
Similar content being viewed by others
References
Crofford LJ (2011) Fibromyalgia. In: Longo DLFA, Kasper D, Hauser S, Jameson J, Loscalzo J (eds) Harrison’s principles of internal medicine, 18th edn. McGraw-Hill Companies, New York
Bidari A, Ghavidel-Parsa B, Ghalehbaghi B (2009) Reliability of ACR criteria over time to differentiate classic fibromyalgia from nonspecific widespread pain syndrome: a 6-month prospective cohort study. Mod Rheumatol 19:663–669
Yunus MB (1992) Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. J Rheumatol 19(6):846–850
Bennett RM (1999) Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc 74(4):385–398
Granges G, Littlejohn G (1993) Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 36(5):642–646
Yunus MB, Ahles TA, Aldag JC, Masi AT (1991) Relationship of clinical features with psychological status in primary fibromyalgia. Arthritis Rheum 34:15–21
Bidari A, Hassanzadeh M, Ghavidel-Parsa B, Kianmehr N, Kabir A, Pirhadi S, et al (2013) Validation of the 2010 American Colleague of Rheumatology preliminary diagnostic criteria for fibromyalgia in an Iranian population. Rheumatol Int [Epub ahead of print]
Hughes G, Martinez C, Myon E et al (2006) The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 54:177
Mease P, Arnold L (2009) Fibromyalgia syndrome module in OMERACT 9: domain construct. J Rheumatol 36(11):2318–2329
White KP, Harth M (1996) An analytical review of 24 controlled clinical trials for fibromyalgia syndrome (FMS). Pain 64:211–219
Meenan RF, Gertman PM, Mason JH (1980) Measuring health status in arthritis. The arthritis impact measurement scales. Arthritis Rheum 23:146–152
Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145
Ware JJ, Sherbourne C (1992) The MOS 36-Item Short-Form Health Survey (SF-36). Med Care 30:473–483
Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728–733
Hawley DJ, Wolfe F (1991) Pain, disability, and pain/disability relationships in seven rheumatic disorders: a study of 1,522 patients. J Rheumatol 18:1552–1557
Wolfe F, Ross K, Anderson J, Russell IJ (1995) Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 22:151–156
El-Naby MA, Hefny MA, Fahim AE, Awadalla MA et al (2013) Validation of an adapted Arabic version of fibromyalgia syndrome impact questionnaire. Rheumatol Int 33(10):2561–2567
Zijlstra TR, Taal E, van de Laar MA, Rasker JJ (2007) Validation of a Dutch translation of the fibromyalgia impact questionnaire. Rheumatology (Oxford) 46:131–134
Perrot S, Dumont D, Guillemin F, Pouchot J, Coste J (2003) Quality of life in women with fibromyalgia syndrome: validation of the QIF, the French version of the fibromyalgia impact questionnaire. J Rheumatol 30:1054–1059
Offenbaecher M, Waltz M, Schoeps P (2000) Validation of a German version of the Fibromyalgia Impact Questionnaire (FIQ-G). J Rheumatol 27:1984–1988
Sarzi-Puttini P, Atzeni F, Fiorini T, Panni B, Randisi G, Turiel M, Carrabba M (2003) Validation of an Italian version of the Fibromyalgia Impact Questionnaire (FIQ-I). Clin Exp Rheumatol 21:459–464
Osada K, Oka H, Isomura T, Nakamura I, Tominaga K, Takahashi S, Kojima A, Nishioka K (2011) Development of the Japanese version of the Fibromyalgia Impact Questionnaire (JFIQ): psychometric assessments of reliability and validity. Int J Rheum Dis 14(1):74–80
Rivera J, Gonzalez T (2004) The Fibromyalgia Impact Questionnaire. A validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol 22:554–560
Hedin PJ, Hamne M, Burckhardt CS, Engstrom-Laurent A (1995) The Fibromyalgia Impact Questionnaire, a Swedish translation of a new tool for evaluation of the fibromyalgia patient. Scand J Rheumatol 24:69–75
Kim YA, Lee SS, Park K (2002) Validation of a Korean version of the fibromyalgia impact questionnaire. J Korean Med Sci 17:220–224
Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20:9–12
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33(2):160–172
Motamed N, Ayatollahi AR, Zare N, Sadeghi-Hassanabadi A (2005) Validity and reliability of the Persian translation of the SF-36 version 2 questionnaire. East Mediterr Health J 11(3):349–357
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:53–63
Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N (2005) Psychometric properties of a Persian-language version of the Beck Depression Inventory, second edition: BDI-II-PERSIAN. Depress Anxiety 21(4):185–192
Wolfe F, Hawley DJ, Goldenberg DL, Russell IJ, Buskila D, Neumann L (2000) The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire. J Rheumatol 27(8):1989–1999
Bennett R (2005) The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 23(Suppl. 39):S154–S162
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Appendix: Persian version of Fibromyalgia Impact Questionnaire (FIQ-P)
Appendix: Persian version of Fibromyalgia Impact Questionnaire (FIQ-P)
Rights and permissions
About this article
Cite this article
Bidari, A., Hassanzadeh, M., Mohabat, MF. et al. Validation of a Persian version of the Fibromyalgia Impact Questionnaire (FIQ-P). Rheumatol Int 34, 181–189 (2014). https://doi.org/10.1007/s00296-013-2883-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-013-2883-0